Plerixafor

Pediatric Oncology Plerixafor vs G-CSF. Graft composition and main outcomes in pediatric cohort with acute leukemia after αβ T cell depleted haplo-HSCT
Svetlana Glushkova • Larisa Shelikhova • Kirill Voronin • Dmitriy Pershin • Viktoria Vedmedskaya • Yakov Muzalevskii • Alexei Kazachenok • Elena Kurnikova • Svetlana Radygina • Svetlana Radygina • Rimma Khismatullina • Alexei Maschan • Michael Maschan
doi.org/10.69690/ODMJ-018-0425-2612
Pediatric Oncology Plerixafor vs G-CSF: Graft Stem Cells Composition in HSCT with αβ T Depletion in Pediatric Cohort
Maria Fadeeva • Svetlana Glushkova • Oyuna Lodoeva • Viktoria Vedmedskaia • Tatiana Sozonova • Ekaterina Malakhova • Elena Kulakovskaya • Elvira Musaeva • Larisa Shelihova • Dmitry Balashov • Michael Maschan • Dmitry Pershin
doi.org/10.69690/ODMJ-018-0425-1212